Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2001-05-11
2008-11-04
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S012200, C530S303000, C424S009100
Reexamination Certificate
active
07446091
ABSTRACT:
This invention relates to a life saving medicament for critically ill patients and a method of treatment. The composition is a pharmaceutically effective amount of a blood glucose regulator which is used to control the blood glucose level.
REFERENCES:
patent: 5000953 (1991-03-01), Ui et al.
patent: 5155031 (1992-10-01), Posner et al.
patent: 5547929 (1996-08-01), Anderson et al.
patent: 5614492 (1997-03-01), Habener
patent: 5618913 (1997-04-01), Brange et al.
patent: 5691386 (1997-11-01), Inman et al.
patent: 5750497 (1998-05-01), Havelund et al.
patent: 5821217 (1998-10-01), Forse et al.
patent: 5861266 (1999-01-01), Ullrich et al.
patent: 5885980 (1999-03-01), Gutierrez et al.
patent: 6277819 (2001-08-01), Efendic
patent: 6335316 (2002-01-01), Hughes et al.
patent: RE37971 (2003-01-01), Baker et al.
patent: 6551992 (2003-04-01), DeFelippis et al.
patent: WO 95/23217 (1995-08-01), None
patent: 97/07814 (1997-03-01), None
patent: 98/08531 (1998-03-01), None
patent: 98/08873 (1998-03-01), None
patent: WO 00/16797 (2000-03-01), None
patent: 00/33839 (2000-06-01), None
patent: WO 01/85256 (2001-11-01), None
patent: 03/028626 (2003-04-01), None
Abstract US 19925044940, Novo Blood Cir.Path.Inst. Derwent Accession No. 1996-096010 [10].
K. O. Case et al., “Nutrition Support in the Critically Ill Patient”, Crit. Care Nurs Q 2000 vol. 22 No. 4. pp. 75-79 (2000).
Y. Sakuri et al., “Stimulation of Muscle Protein Synthesis By Long-Term Insulin Infusion in Severly Burned Patients”, Annals of Surgery, vol. 222, No. 3, pp. 283-297(1995).
K.C. McCowen et al., “Stress-Induced Hyperglycemia”, Critical Care Clinics vol. 17, No. 1, pp. 107-124 (2001).
Press Release “Clinical Study demonstrates impressive life-saving Effects of insulin by tight control of glucose in intensive care patients” pp. 1-3 (Nov. 8, 2001).
UK Prosperctive Diabetes Study (UKPDS) Group “Intensive blood-glucose Control with supphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes” The Lancet vol. 352. pp. 837-853 (1998).
Nathan et al., “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus” The New England Journal of Medicine, vol. 329, No. 14. pp. 977-986 (1993).
G. Van Den Berghe et al., “Intensive Insulin Therapy in Critically Ill Patients” The New England Journal of Medicine. vol. 345, No. 19 pp. 1359-1367 (2001).
Zochodne et al “Critical Illness Polyneuropathy-A Complication of Sepsis and Multiple Organ Failure” Brain vol. 110, pp. 819-842 (1987).
Leijten et al, “Critical Illness Polyneuropathy—A review of the literature, definition and pathophysiology” Clinical Nuerology and And Neurosurgery. vol. 96. pp. 10-19 (1994).
C.F. Bolton “7.8 Acute Weakness” 7 The Neurological System, pp. 490-495.
C.F. Bolton, “Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations” Crit Care Med. vol. 24, No. 8, pp. 1408-1416 (1996).
R.R.Wolfe et al., “Glucose Metabolism in Man: Responses to Intravenous Glucose Infusion” Metabolism, vol. 28 No. 3. pp. 210-220 (1979).
R. R. Wolfe et al., “Effect of Severe Burn Injury on Substrates Cycling by Glucose and Fatty Acids” The New England Journal of Medicine, vol. 317, No. 7, pp. 403-408 (1987).
R.E.Shangraw et al., “Differentiation Between Septic and Postburn Insulin Resistance”, Metabolism, vol. 38, No. 10. pp. 983-989 (1989).
B.A. Mizock et al., “Alterations in Carbohydrate Metabolism During Stress: A Review of the Literature” The American Journal of Medicine, vol. 98, pp. 75-84 (1995).
K.C. McCowen et al., “Stress-Induced Hyperglycemia” Critical care Clinics, vol. 17, No. 1, pp. 107-124 (2001).
R. Fietsman et al., “Complications of Coronary Artery Surgery in Diabetic Patients” The American Surgeon vol. 57, pp. 551-557 (1991).
P.A.O'Neill et al., “Stress Hormone and Blood Glucose Response Following Acute Stroke in the Elderly” Stroke,vol. 22,pp. 42-847 (1991).
J.F. Scott et al., “Glucose Potassium Insulin Infusions in the Treatment of Acute Stroke Patients with Mild to Moderate Hyperglycemia” The Glucose Insulin in Stroke Trial (GIST) Stroke, vol. 30, pp. 793-799 (1999).
K. Malmberg et al., “Glycometabolic State at Admission:Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction” Circulation vol. 99, pp. 2626-2632 (1999).
K. Malmberg, “Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in Patients with diabetes mellitus” BMJ, vol. 314:1512, pp. 1-12(1997).
K. Malmberg et al., “Randomized Trial of Insulin-Glucose Infusion Followed by Subcutaneous Insulin Treatment in Diabetic Patients With Acute Myocardial Infarction (GIGAMI Study) :Effects on Mortality at 1 Year” J. Am. Coll Cardio vol. 26, pp. 57-65 (1995).
G. Van Den Berghe et al., “Reactivation of Pituitary Hormone Release and Metabolic Improvement by Infusion of Growth Hormone-Releasing Peptide and Thyrotropin-Releasing Hormone in Patients with Protracted Critical Illness” The Journal of Clinical Endocrinology & Metabolism. vol. 84, No. 4, pp. 1311-1323 (1999).
G. Van Den Berghe et al., “A Paradoxical Gender Dissociation within the Growth Hormone/Insulin-Like Growth Factor I Axis during Protracted Critical Illness” The Journal of Clinical Endocrinology & Metabolism vol. 85. No. 1 pp. 183-192 (2000).
A. Ortiz et al., “Expression of Apoptosis-Regulatory Genes in Renal Proximal Tubular Epithelial Cells Exposed to High Ambient Glucose and In Diabetic Kidneys” Journal of Investigative Medicine vol. 45, No. 2 pp. 50-56 (1997).
Gerard Said et al., “Severe Early-Onset Polyneuropathy in Insulin-Dependent Diabetes Mellitus” The New England Journal of Medicine vol. 326, No. 19, pp. 1257-1263 (1992).
Wiley W. Souba “Nutritional Support” The New England Journal of Medicine Vo. 336 No. 1. pp. 41-48 (1997).
W.A. Knaus et al., “APACHE II: A severity of disease classification system” Critical Care Medicine Vo. 13. No. 10. pp. 818-829 (1985).
D.R. Miranda et al., “Simplified Therapeutic Intervention Scoring System: The TISS-28 items-Results from a multicenter study” Crit Care Med. vol. 24, No. 1. pp. 64-73 (1996).
A. R. Keene et al, “Therapeutic Intervention Scoring System: Update 983” Crit Care Med. vol. 11. No. 1. pp. 1-3 (1983).
W.A. Knaus “Measuring the Glasgow Coma Scale In the Intensive Care Unit: Potentials and Pitfalls” Intensive Care World p. 102.
M.P. Weinstein et al., “Clinical Importance of Identifying Coagulase-Negative Staphylococci Isolated from Blood Cultures: Evaluation of The Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia In Adults” Clinical Infectious Diseases. vol. 24, pp. 584-602(1997).
C.S. Levetan et al., “Hospital Management of Diabetes” Acute Complications of Diabetes vol. 29. No. 4. pp. 745-770(2000).
J. Takala et al., “Increased Mortality Associated With Growth Hormone Treatment in Critically Ill Adults” The New England Journal of Medicine vol. 341. No. 11. pp. 785-792 (1999).
K.G.M.M. Albert et al., “Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Part 1: Diagnosis and Class-Sification of Diabetes Mellitu Provisional Report of a WHO Consultation” Diabetic Medicine vol. 15, pp. 539-543 (1998).
S.E. Capes et al., “Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes:a Systematic overview” The Lancet vol. 355, pp. 773-778 (2000).
G.R. Bernard et al., “Efficacy and Safety of Recombinan
Bork Richard W.
Kam Chih-Min
Novo Nordisk A S
LandOfFree
Methods and preparations for curing clinically ill patients does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and preparations for curing clinically ill patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and preparations for curing clinically ill patients will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026174